Total Funding
51
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Accelalox Inc. is a privately held company developing therapies to treat musculoskeletal conditions. Our initial development program is
J. Patrick O’Connor: Chief Scientific Officer and Founder
About the Company
Accelalox Inc. is a privately held company developing therapies to treat musculoskeletal conditions. Our initial development program is focused on an oral, small-molecule therapy to significantly accelerate and enhance bone healing. This therapy will be used for bone fractures and spinal fusions to improve patient outcomes through accelerated
healing and reduced complications.
Women Led
